Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.

Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC.

Vaccine. 2011 May 9;29(20):3633-9. doi: 10.1016/j.vaccine.2011.03.029. Epub 2011 Apr 5.

PMID:
21440036
2.

Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine.

Yang CF, Belshe RB, Kemble G, Song E, Ye D, Liang B, Yi T, Ambrose CS, Coelingh K, Walker RE.

Vaccine. 2010 Jul 12;28(31):5128-34. doi: 10.1016/j.vaccine.2010.02.109. Epub 2010 May 14.

PMID:
20472026
3.

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

Belshe RB, Toback SL, Yi T, Ambrose CS.

Influenza Other Respir Viruses. 2010 May 1;4(3):141-5. doi: 10.1111/j.1750-2659.2009.00124.x.

4.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ.

BMC Infect Dis. 2010 Mar 17;10:71. doi: 10.1186/1471-2334-10-71.

5.

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older.

De Villiers PJ, Steele AD, Hiemstra LA, Rappaport R, Dunning AJ, Gruber WC, Forrest BD; LAIV Elderly Study Trial Network.

Vaccine. 2009 Dec 10;28(1):228-34. doi: 10.1016/j.vaccine.2009.09.092. Epub 2009 Sep 29.

PMID:
19796721
6.

Comparative efficacy of inactivated and live attenuated influenza vaccines.

Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC.

N Engl J Med. 2009 Sep 24;361(13):1260-7. doi: 10.1056/NEJMoa0808652.

7.

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52. Erratum in: MMWR Recomm Rep. 2009 Aug 21;58(32):896-7.

8.

Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members.

Eick AA, Wang Z, Hughes H, Ford SM, Tobler SK.

Vaccine. 2009 Jun 2;27(27):3568-75. doi: 10.1016/j.vaccine.2009.03.088. Epub 2009 Apr 19.

PMID:
19464536
9.

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.

Wang Z, Tobler S, Roayaei J, Eick A.

JAMA. 2009 Mar 4;301(9):945-53. doi: 10.1001/jama.2009.265. Epub 2009 Mar 2.

PMID:
19255113
10.

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.

Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.

PMID:
19095024
11.

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

Belshe RB, Ambrose CS, Yi T.

Vaccine. 2008 Sep 12;26 Suppl 4:D10-6. doi: 10.1016/j.vaccine.2008.06.083.

PMID:
18611422
12.

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, Kemble G, Allende M, Hultquist M, Yi T, Nowak B, Weinberg A.

Vaccine. 2008 Aug 5;26(33):4210-7. doi: 10.1016/j.vaccine.2008.05.054. Epub 2008 Jun 10.

13.

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.

Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, Newton DW, Campbell SA, Boulton ML, Monto AS.

J Infect Dis. 2008 Aug 1;198(3):312-7. doi: 10.1086/589885.

14.

Vaccines for preventing influenza in healthy children.

Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004879. doi: 10.1002/14651858.CD004879.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD004879.

PMID:
18425905
15.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
16.

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

Halloran ME, Piedra PA, Longini IM Jr, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.

Vaccine. 2007 May 16;25(20):4038-45. Epub 2007 Mar 12.

17.

Live attenuated versus inactivated influenza vaccine in infants and young children.

Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group.

N Engl J Med. 2007 Feb 15;356(7):685-96. Erratum in: N Engl J Med. 2007 Mar 22;356(12):1283.

18.

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines.

Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS.

N Engl J Med. 2006 Dec 14;355(24):2513-22.

19.

Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.

Gorse GJ, O'connor TZ, Young SL, Habib MP, Wittes J, Neuzil KM, Nichol KL.

Chest. 2006 Oct;130(4):1109-16.

PMID:
17035445
20.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
Items per page

Supplemental Content

Write to the Help Desk